Meeting
2019 Gastrointestinal Cancers Symposium
Comprehensive genomic profiling in metastatic pancreatic adenocarcinoma, correlation with early death versus prolonged survival.
Authors
Mandana Kamgar
Karmanos Cancer Institute, Wayne State University, Detroit, MI
Mandana Kamgar , Gregory Dyson , Anthony Frank Shields , Anteneh A. Tesfaye , Philip Agop Philip , Mohammed Najeeb Al Hallak
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 282)
DOI
10.1200/JCO.2019.37.4_suppl.282
Abstract #
282
Poster Bd #
E20
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Monocyte to lymphocyte ratios and cancer-specific mortality for patients with renal cell carcinoma and inferior vena cava tumor thrombus.
First Author: Maxwell Sandberg
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of site of metastases in pancreatic ductal adenocarcinoma.
First Author: Adeel Arshad
Poster
2022 ASCO Annual Meeting
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy.
First Author: Andrea Pretta
Poster
2022 ASCO Annual Meeting
KRAS wild-type pancreatic ductal adenocarcinoma: Molecular and therapeutic opportunities.
First Author: Aakash Desai